Bouvel Investment Partners LLC Sells 2,768 Shares of Aspen Aerogels, Inc. (NYSE:ASPN)

Bouvel Investment Partners LLC cut its position in shares of Aspen Aerogels, Inc. (NYSE:ASPN) by 3.0% during the 3rd quarter, Holdings Channel reports. The firm owned 90,992 shares of the construction company’s stock after selling 2,768 shares during the quarter. Bouvel Investment Partners LLC’s holdings in Aspen Aerogels were worth $2,520,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors also recently made changes to their positions in the company. BNP Paribas Financial Markets raised its holdings in shares of Aspen Aerogels by 85.2% during the 1st quarter. BNP Paribas Financial Markets now owns 25,706 shares of the construction company’s stock worth $452,000 after buying an additional 11,823 shares in the last quarter. Oppenheimer & Co. Inc. bought a new stake in shares of Aspen Aerogels in the 1st quarter valued at $388,000. Swiss National Bank boosted its position in shares of Aspen Aerogels by 16.2% during the 1st quarter. Swiss National Bank now owns 120,500 shares of the construction company’s stock worth $2,121,000 after purchasing an additional 16,800 shares in the last quarter. Vanguard Group Inc. raised its position in shares of Aspen Aerogels by 5.1% during the first quarter. Vanguard Group Inc. now owns 3,619,702 shares of the construction company’s stock worth $63,707,000 after purchasing an additional 175,906 shares during the period. Finally, Healthcare of Ontario Pension Plan Trust Fund acquired a new position in shares of Aspen Aerogels during the first quarter valued at about $851,000. 97.64% of the stock is currently owned by institutional investors.

Insider Activity

In other Aspen Aerogels news, CFO Ricardo C. Rodriguez sold 32,465 shares of the firm’s stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $30.14, for a total transaction of $978,495.10. Following the completion of the transaction, the chief financial officer now directly owns 20,790 shares in the company, valued at approximately $626,610.60. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. In other news, CFO Ricardo C. Rodriguez sold 32,465 shares of the company’s stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $30.14, for a total value of $978,495.10. Following the sale, the chief financial officer now owns 20,790 shares in the company, valued at approximately $626,610.60. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO Donald R. Young sold 63,355 shares of the business’s stock in a transaction dated Monday, September 30th. The shares were sold at an average price of $30.03, for a total value of $1,902,550.65. Following the completion of the sale, the chief executive officer now directly owns 483,640 shares of the company’s stock, valued at approximately $14,523,709.20. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 4.30% of the company’s stock.

Wall Street Analyst Weigh In

ASPN has been the topic of a number of research analyst reports. Roth Mkm cut their price target on shares of Aspen Aerogels from $36.00 to $31.00 and set a “buy” rating on the stock in a report on Friday, November 8th. HC Wainwright reaffirmed a “buy” rating and set a $30.00 price objective on shares of Aspen Aerogels in a report on Wednesday, October 16th. TD Cowen boosted their price objective on shares of Aspen Aerogels from $36.00 to $41.00 and gave the stock a “buy” rating in a report on Tuesday, August 20th. StockNews.com raised shares of Aspen Aerogels to a “sell” rating in a research report on Wednesday. Finally, Piper Sandler decreased their price objective on shares of Aspen Aerogels from $36.00 to $33.00 and set an “overweight” rating for the company in a report on Tuesday, October 22nd. One equities research analyst has rated the stock with a sell rating, nine have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $28.70.

Aspen Aerogels Stock Performance

NYSE:ASPN opened at $15.54 on Thursday. The company has a debt-to-equity ratio of 0.27, a quick ratio of 2.82 and a current ratio of 2.93. The stock has a market capitalization of $1.28 billion, a P/E ratio of 1,555.56 and a beta of 2.21. The company has a 50 day moving average price of $22.66 and a 200 day moving average price of $24.74. Aspen Aerogels, Inc. has a fifty-two week low of $9.57 and a fifty-two week high of $33.15.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.